Skip to content

Study on the correlation between LT-a and MMP-9 expression and efficacy in contact lens-related dry tears

Analysis of the correlation between lymphotoxin-a and matrix metalloproteinase-9 levels in tears from contact lens-related dry eye and treatment efficacy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127662
Enrollment
Unknown
Registered
2026-07-04
Start date
2026-07-10
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contact lens-associated dry eye syndrome (CLDE)

Interventions

control group:Use 0.1% sodium hyaluronate eye drops, 2 weeks.
experimental group:Use Cationorm eye drops, 2 weeks

Sponsors

Tianjin Medical University Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.Adult volunteers aged 18~40 years with refractive errors (-0.50D ~ -6.00D) and no other eye diseases; 2.Able to understand and voluntarily sign written informed consent forms, and cooperate throughout the entire research process; 3.Voluntarily wear contact lenses for 2 weeks; 4.Voluntary use of Cationorm eye drops or 0.1% sodium hyaluronate eye drops for 2 weeks; 5.No subjective symptoms related to dry eye, baseline OSDI score <10, NITBUT normal, corneal and conjunctival staining score of 0.

Exclusion criteria

Exclusion criteria: 1. Presence of active eye infections (such as conjunctivitis, keratitis, blepharitis, etc.); 2. Have undergone any eye surgery within the last 3 months prior to enrollment; 3. Have a history of contact lens allergy or are allergic to the components of the eye drops used in this study; 4. Systemic immunosuppressive therapy initiated within 3 months prior to enrollment; 5. Patients with systemic diseases affecting the ocular surface (such as Sjögren's syndrome, diabetes, rheumatoid arthritis, etc.) or those using medications that may affect the ocular surface; 6. Women who are pregnant, breastfeeding, or planning to become pregnant during the study; 7. Having mental illness or cognitive impairment, unable to cooperate with research procedures; 8. The investigator determines that there are other circumstances unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
tear MMP-9 concentration (pg/mL);tear LTA concentration (pg/mL);Corneal and conjunctival staining (CS) score;

Countries

China

Contacts

Public ContactRen Xinjun

Tianjin Medical University Eye Hospital

zlrxjrsy@126.com+86 22 86428838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026